Kalaris Therapeutics GAAP EPS of -$0.48 in-line — See source for full details.
$KLRS
Price history, market instrument context, member research, and related headlines in one place.
KLRS key statistics
NasdaqGMUSD
52-week range
$2.101%$11.88
Latest session $2.10–$2.23Kalaris Therapeutics, Inc. (KLRS) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $2.19, up $0.06 (2.82%) from the previous close of $2.13. It has traded between $2.10 and $2.23 in the latest session. Over the past year it has ranged from $2.10 to $11.88, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 57K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $KLRS research…